US Patent Issued to The University of Chicago, Anokion on Aug. 12 for "Compositions and methods concerning immune tolerance" (American, Swiss Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,617, issued on Aug. 12, was assigned to The University of Chicago (Chicago) and Anokion SA (Ecublens, Switzerland).

"Compositions and methods concerning immune tolerance" was invented by Jeffrey A. Hubbell (Chicago), David Scott Wilson (Chicago), Kym Brunggel (Chicago) and Kristen Marie Lorentz (Ecublens, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions comprising mannose-fused antigens to target mannose receptors. The compositions may be used to prevent immunity or reduce an immune response protein-based drugs that would otherwise elicit an immune response."

The patent was filed on May 9, 2019...